Identifying Prognostic Indicators in Staging Metastatic Sarcomas Using Hospital Episode Statistics

REFERENCES

• National Cancer Intelligence Network: Soft Tissue Sarcoma Incidence and Survival: Tumours Diagnosed in England Between 1985 and 2009. [Accessed 19 June 2014 from http://www.ncin. org.uk].
   Google Scholar
• Sobin L, Gospodarowicz M, Wittekind (Eds). TNM Classification of Malignant Tumours, 7th edition. Wiley-Blackwell, 2009.
   Google Scholar
• Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007;12:20–37.
   PubMed Web of Science ®Google Scholar
• Casali PG, Blay JY. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):198–203.
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F. (Eds). World Health Organisation Classification of tumours: Tumours of Soft Tissue and Bone. Geneva: WHO Press; 2013.
   Google Scholar
• World Health Organisation: International Classification of Diseases for Oncology, 3rd edition (ICD-O-3). Lyon, France: IARC Press, 2000. [http://www.who.int/classifications/icd/ adaptations/oncology/en/]
   Google Scholar
• World Health Organisation: International Statistical Classification of Diseases and Related Health Problems. Geneva: WHO. [http://www.who.int/classifications/icd/en/]
   Google Scholar
• Edge SB, Byrd DR, Carducci MA. et al (Eds). American Joint Committee on Cancer (AJCC) AJCC Cancer Staging Manual 7th edition (p. 5). New York: Springer, 2009.
   Google Scholar
• Fay MP, Feuer EJ. Confidence intervals for directly standardised rates: A method based on the gamma distribution. Statistics in Medicine 1997;16:791–801.
   PubMed Web of Science ®Google Scholar
• Waterhouse J, Muir CS, Correa P, Powell J. (Eds.). Cancer Incidence in Five Continents. Lyon: IARC, 1976.
   Google Scholar
• Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. No. 10. Methodological note. End Results Evaluation Section ( p. 456). Bethesda, MD: National Cancer Institute, 1959.
   Google Scholar
• Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS. Small round cell sarcomas. Semin Oncol 2009;36:338–346.
   PubMed Web of Science ®Google Scholar
• Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Bielack SS. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011–2018.
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Winkler K. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2002;20:776–790.
   PubMed Web of Science ®Google Scholar
• Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am 2013;95(13):e89.
   PubMedGoogle Scholar
• Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voute PA, Gadner OH, Craft AW. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000;18:3108–3114.
   PubMed Web of Science ®Google Scholar
• Esiashvili N, Goodman M, Marcus RB. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Onc 2008;30:425–430.
   PubMed Web of Science ®Google Scholar
• Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registry. Cancer 2010;116:1964–1973.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 2008;19:814–820.
   PubMed Web of Science ®Google Scholar
• Jawad MU, Haleem AA, Scully SP.: Malignant Sarcoma of the Pelvic Bones. Cancer 2011;117(7):1529–41.
   PubMed Web of Science ®Google Scholar
• Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M.-J. (Eds). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics ( pp. 81–88). Bethesda, MD: National Cancer Institute, SEER Program NIH, 2007.
   Google Scholar
• Ardoino I, Miceli R, Berselli M, Mariani L, Biganzoli E, Fiore M, Collini P, Stacchiotti S, Casali PG, Gronchi A. Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma. Cancer 2010;116:2429–2436.
   PubMed Web of Science ®Google Scholar
• Stoeckle E, Coindre JM, Bonvalot S, Kantor G, Terrier P, Bonichon F, Nguyen Bui B. Prognostic factors in retroperitoneal sarcoma. Cancer 2001;92:359–368.
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355–365.
   PubMed Web of Science ®Google Scholar
• Krieg AH, Hefti F, Speth BM, Jundt G, Guillou L, Exner UG, Hochstetter AR, von Cserhati MD, Fuchs B, Mouhsine E, Kaelin A, Klenke FM, Siebenrock KA. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Annals of Oncology 2011;22:458–467.
   PubMed Web of Science ®Google Scholar
• Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998;22:683–697.
   PubMed Web of Science ®Google Scholar
• Fayette J, Martin E, Piperno-Neumann S, Le Cesne A, Robert C, Bonvalot S, Ranchère D, Pouillart P, Coindre JM, Blay JY. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol 2007;18:2030–2036.
   PubMed Web of Science ®Google Scholar
• Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist 1999;4:34–44.
   PubMedGoogle Scholar
• Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Hensley ML. Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on cancer staging systems. J Clin Oncol 2009;27:2066–2072.
   PubMed Web of Science ®Google Scholar
• Tan PS, Koh E, Pang C, Ong WS, Ngo L, Soh LT, Lim T. Uterine leiomyosarcoma in asian patients: Validation of the revised federation of gynecology and obstetrics staging system and identification of prognostic classifiers. Oncologist 2012;17(10):1286–1293.
   PubMed Web of Science ®Google Scholar
• Baker KS, Anderson JR, Link MP, Holcombe EG, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 2000;18(12): 2427–2434.
   PubMed Web of Science ®Google Scholar
• McCarville MB, Spunt SL, Pappo AS. Rhabdomyosarcoma in pediatric patients the good the bad and the unusual. Am J Roentgenol 2001;176(6):1563–1569.
   PubMed Web of Science ®Google Scholar